Regulations Archives - Page 14 of 193

2 minute read

Microsoft’s $75B Acquisition of Activision Cleared of Insider Trading Concerns by SEC

May 2, 2:43 PM

The SEC & Justice Dept found no grounds for charges after investigating Barry Diller, Alexander von Furstenberg & David Geffen's investments in Activision before Microsoft's acquisition.

FTEC

2 minute read

Stellantis Adapts to EV Challenge, Follows Tesla’s Lead by Cutting Costs Through Global Job Shifts

By Anusuya Lahiri

May 2, 9:15 AM

Stellantis NV (NYSE: STLA) shifting engineering recruitment to lower-cost countries due to cheaper Chinese EVs and CEO criticism, stock up 38% in last 12 months.

FTHI

2 minute read

Uber Vs. London’s Black Cab: Company Faces $310M Claim from Drivers

By Anusuya Lahiri

May 2, 9:03 AM

Uber (NYSE: UBER) faces a £250 million lawsuit by over 10,500 London black-cab drivers, accusing the company of unlawfully diverting business from traditional taxi operators.

FPX

1 minute read

Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

By Benzinga Newsdesk

May 2, 3:26 AM

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval

CLVT

2 minute read

Federal Trade Commission Targets ‘Junk Patent Listings’ For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca

By Vandana Singh

May 1, 4:11 PM

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic competition.

AMPH

3 minute read

Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement

By Nicolas Jose Rodriguez

May 1, 2:25 PM

Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.

ACB

2 minute read

DEA Moves To Reschedule Weed, Cannabis Stocks Go For Wild Ride, Pummel Short Sellers With $210M In Losses

By Maureen Meehan

May 1, 12:23 PM

Cannabis stocks soared following Tuesday's news that the DEA intends to designate marijuana from Schedule I to Schedule III.

CGC

2 minute read

After Nvidia and Apple, Alibaba Chases Vietnam: New Data Center to Boost Control and Meet Local Laws

By Anusuya Lahiri

May 1, 11:21 AM

Alibaba to build data center in Vietnam to comply with local storage law and meet demand. Other tech firms also diversifying to Vietnam.

AAPL

4 minute read

Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady

By Nicolas Jose Rodriguez

April 30, 6:35 PM

In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.

ACB

2 minute read

Cannabis Industry Leaders React To DEA’s Historic Rescheduling of Cannabis

By Rolando García

April 30, 3:58 PM

the U.S. Drug Enforcement Administration (DEA) is reportedly moving cannabis from Schedule I to Schedule III

INQD